This inventor holds 2 USPTO granted patents. Top assignee: Toyo Jozo Company, Ltd.. Active years: 1981-1987.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1981-1987
Title: Masaru Ono: Innovator in Macrolide Antibiotics
Introduction
Masaru Ono is a distinguished inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of macrolide antibiotics. With a total of 2 patents, Ono's work has the potential to impact medical treatments significantly.
Latest Patents
Ono's latest patents include a stable oral preparation of macrolide antibiotics and a novel microorganism species capable of producing new macrolide antibiotics. The first patent focuses on creating stable oral preparations of 16-membered ring macrolide antibiotics, such as SF-837 and josamycin. This preparation incorporates stabilizers and dissolution accelerators to enhance the stability of the antibiotics. The second patent introduces a new microorganism, Micromonospora sp. A 11725, which produces novel antibiotics A 11725 I, A 11725 II, and A 11725 III. These antibiotics exhibit excellent antibacterial and anti-mycoplasmal activities, making them valuable for various medical applications.
Career Highlights
Masaru Ono is currently associated with Toyo Jozo Company, Ltd., where he continues to innovate in the field of antibiotic development. His work has garnered attention for its potential to improve the efficacy and stability of antibiotic treatments.
Collaborations
Ono has collaborated with notable colleagues, including Masataka Morishita and Yukio Sumita, to advance his research and development efforts in the pharmaceutical industry.
Conclusion
Masaru Ono's contributions to the field of macrolide antibiotics highlight his innovative spirit and dedication to improving medical treatments. His patents reflect a commitment to addressing critical health challenges through scientific advancement.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile